1‐year overall mortality · ambulatory paediatric cancer patients newly diagnosed with acute lymphoblastic leukaemia who received chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinically relevant bleeding · ambulatory cancer patients receiving chemotherapy
DOAC showed no clear difference in clinically relevant bleeding compared with placebo (moderate certainty).
1 finding from 1 review
Clinically relevant bleeding · ambulatory paediatric cancer patients newly diagnosed with acute lymphoblastic leukaemia who received chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptomatic VTE · ambulatory cancer patients receiving chemotherapy
Low‐molecular‐weight heparin leads to lower symptomatic VTE compared with no thromboprophylaxis (high certainty).
1 finding from 1 review
Major bleeding · ambulatory cancer patients receiving chemotherapy
Low‐molecular‐weight heparin probably leads to higher major bleeding compared with no thromboprophylaxis (moderate certainty).
1 finding from 1 review
Diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
Diarrhoea · participants with cancer treated with chemotherapy
Probiotics may leads to lower any diarrhoea compared with placebo (low certainty).
1 finding from 1 review
Quality of life ‐ not measured · participants with cancer treated with chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (grade 2+) · participants with cancer treated with chemotherapy
Probiotics showed no clear difference in diarrhoea grade 2 or higher compared with placebo (low certainty).
1 finding from 1 review
Grade 3 to 4 diarrhoea · participants with cancer treated with chemotherapy
Probiotics showed no clear difference in diarrhoea grade 3 or higher compared with placebo (low certainty).
1 finding from 1 review
Diarrhoea grade 4 · participants with cancer treated with chemotherapy
Probiotics showed no clear difference in diarrhoea grade 4 compared with placebo (low certainty).
1 finding from 1 review
Time to rescue medication ‐ not measured · participants with cancer treated with chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Requiring rescue medication for diarrhoea · participants with cancer treated with chemotherapy
1 finding from 1 review
Adverse events · participants with cancer treated with chemotherapy
1 finding from 1 review
All‐cause mortality · participants with cancer treated with chemotherapy
1 finding from 1 review
Diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
It is very uncertain whether probiotics changes any diarrhoea compared with other active treatment (very low certainty).
1 finding from 1 review
Quality of life · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
Quality of life ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Grade ≥ 3 diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
Probiotics may leads to lower severity of diarrhoea: grade 3 or higher compared with other active treatment (low certainty).
1 finding from 1 review
Time to rescue medication ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found